Cargando…
Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial
BACKGROUND: The use of cardiovascular medication for the primary prevention of cardiovascular disease (CVD) is potentially inappropriate when potential risks outweigh the potential benefits. It is unknown whether deprescribing preventive cardiovascular medication in patients without a strict indicat...
Autores principales: | Luymes, Clare H., Poortvliet, Rosalinde K. E., van Geloven, Nan, de Waal, Margot W. M., Drewes, Yvonne M., Blom, Jeanet W., Smidt, Nynke, Assendelft, Willem J. J., van den Hout, Wilbert B., de Ruijter, Wouter, Numans, Mattijs E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763574/ https://www.ncbi.nlm.nih.gov/pubmed/29321031 http://dx.doi.org/10.1186/s12916-017-0988-0 |
Ejemplares similares
-
Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients
por: Luymes, Clare H, et al.
Publicado: (2017) -
Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
por: van Peet, Petra G., et al.
Publicado: (2015) -
Assessment of Appropriateness of Cardiovascular Preventive Medication in Adults ≥ 75 years
por: van der Ploeg, Milly, et al.
Publicado: (2020) -
How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
por: Mantelli, Sophie, et al.
Publicado: (2018) -
Ecstatic and gelastic seizures relate to the hypothalamus
por: Roodakker, Kenney Roy, et al.
Publicado: (2020)